InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

What symbol and exchange does Inspiremd shares trade?

Inspiremd trades on the NASDAQ stock market under the symbol NSPR.

What is Inspiremd stock price doing today?

As of November 6, 2026, NSPR stock price climbed to $0.70 with 339,170 million shares trading.

What is Inspiremd's Beta?

NSPR has a beta of 0.60, meaning it tends to be less sensitive to market movements. NSPR has a correlation of 0.01 to the broad based SPY ETF.

How much is Inspiremd worth?

NSPR has a market cap of $32.60 million. This is considered a Sub-Micro Cap stock.

How much money does Inspiremd make?

Last quarter Inspiremd reported $2 million in Revenue and -$.17 earnings per share. This beat revenue expectation by $334,600 and exceeded earnings estimates by $.03.

What is the highest and lowest price Inspiremd traded in the last 3 year period?

In the last 3 years, NSPR traded as high as $3.80 and as low as $.43.

What are the top ETFs holding Inspiremd?

The top ETF exchange traded funds that NSPR belongs to (by Net Assets): IWC.

Is Inspiremd (NSPR) a good investment?

NSPR has underperformed the market in the last year with a return of -67.0%, while SPY returned +9.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NSPR shares. However, NSPR has outperformed the market in the last 3 month and 2 week periods, returning -3.3% and +53.0%, while SPY returned -4.2% and -3.8%, respectively. This indicates NSPR has been having a stronger performance recently.

What are the support and resistance levels for Inspiremd (NSPR)?

NSPR support price is $.58 and resistance is $.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NSPR shares will trade within this expected range on the day.